Presence of Cutaneous Complement Deposition Distinguishes between Immunological and Histological Features of Bullous Pemphigoid-Insights from a Retrospective Cohort Study

被引:7
|
作者
Staender, Sascha [1 ]
Holtsche, Maike M. [1 ]
Schmidt, Enno [1 ,2 ]
Hammers, Christoph M. [2 ]
Zillikens, Detlef [1 ]
Ludwig, Ralf J. [1 ,2 ]
Kridin, Khalaf [2 ]
机构
[1] Univ Lubeck, Dept Dermatol, D-23562 Lubeck, Germany
[2] Univ Lubeck, Lubeck Inst Expt Dermatol, D-23562 Lubeck, Germany
关键词
BP; bullous pemphigoid; complement; direct immunofluorescence; immunological; morphological; XVII COLLAGEN; BLISTER FORMATION; SERUM-LEVELS; AUTOANTIBODIES; BP180; SKIN; IGG; ACTIVATION; ANTIBODIES; INDUCTION;
D O I
10.3390/jcm9123928
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The practical implications of complement deposition in direct immunofluorescence (DIF) microscopy and its influence on the disease phenotype are poorly understood. We aimed to investigate whether the presence of complement deposition in DIF microscopy gives rise to differences in the morphological, immunological, and histological characteristics of patients with BP (bullous pemphigoid). We performed a retrospective study encompassing patients with BP in a specialized tertiary referral center. Logistic regression model was utilized to identify variables independently associated with complement deposition. The study included 233 patients with BP, of whom 196 (84.1%) demonstrated linear C3 deposition along the dermal-epidermal junction (DEJ) in DIF analysis. BP patients with C3 deposition had higher mean (SD) levels (645.2 (1418.5) vs. 172.5 (243.9) U/mL; p < 0.001) and seropositivity rate (86.3% vs.64.9%; p = 0.002) of anti-BP180 NC16A and less prevalent neutrophilic infiltrate in lesional skin specimens (29.8% vs. 52.4%; p = 0.041). C3 deposition was found positively associated with the detection of anti-BP180 NC16A autoantibodies (OR, 4.25; 95% CI, 1.38-13.05) and inversely associated with the presence of neutrophils in lesional skin (OR, 3.03; 95% CI, 1.09-8.33). To conclude, complement deposition influences the immunological and histological features of BP. These findings are in line with experimental data describing the pathogenic role of complement in BP.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 5 条
  • [1] Immunological features and factors associated with mucocutaneous bullous pemphigoid - a retrospective cohort study
    Staender, Sascha
    Schmidt, Enno
    Zillikens, Detlef
    Ludwig, Ralf J.
    Kridin, Khalaf
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (09): : 1289 - 1295
  • [2] Association Between Bullous Pemphigoid and Dipeptidyl Peptidase 4 Inhibitors: A Retrospective Cohort Study
    Magdaleno-Tapial, J.
    Valenzuela-Onate, C.
    Esteban Hurtado, A.
    Ortiz-Salvador, J. M.
    Subiabre-Ferrer, D.
    Ferrer-Guillen, B.
    Giacaman-von der Weth, M.
    Garcia-Legaz Martinez, M.
    Martinez-Domenech, A.
    Hernandez-Bel, P.
    Esteve-Martinez, A.
    Perez-Pastor, G.
    Zaragoza-Ninet, V
    Garcia-Rabasco, A.
    Martinez-Aparicio, A.
    Sanchez-Carazo, J. L.
    Perez-Ferriols, A.
    Alegre-de Miquel, V
    ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (03): : 249 - 253
  • [3] Clinical Features between Young and Elderly Patients with Bullous Pemphigoid: An Age-Matched Case Control Retrospective Study
    Dong, Qi
    Han, Dawei
    Wang, Kevin Y.
    Feng, Hua
    Wang, Meng
    Xu, Qingqiang
    Zhang, Shiyu
    Zuo, Yagang
    Liu, Yuehua
    Jin, Hongzhong
    Wang, Tao
    Zdravkovic, Tanja Prunk
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2021, 15 (01) : 78 - 81
  • [4] Association between dipeptidyl peptidase-4 inhibitors and increased risk for bullous pemphigoid within 3 months from first use: A 5-year population-based cohort study using the Japanese National Database
    Kuwata, Hirohito
    Nishioka, Yuichi
    Noda, Tatsuya
    Kubo, Shinichiro
    Myojin, Tomoya
    Higashino, Tsuneyuki
    Takahashi, Yutaka
    Ishii, Hitoshi
    Imamura, Tomoaki
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (03) : 460 - 467
  • [5] Clinical features and treatment outcomes for primary cutaneous CD4+small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review
    Plumptre, Isabella R.
    Said, Jordan T.
    Sun, Tiffany
    Larocca, Cecilia
    Virgen, Cesar A.
    Kupper, Thomas S.
    Fisher, David C.
    Devlin, Philip M.
    Elco, Christopher P.
    Song, Johanna Sheu
    LeBoeuf, Nicole R.
    LEUKEMIA & LYMPHOMA, 2022, 63 (12) : 2832 - 2846